The present results provided a novel insight into not only the mechanical regulation mechanism and its molecular basis in the interaction of DNAM-1 with CD155, but also the immune diagnosis and treatment of tumor or autoimmune diseases related to the DNAM-1/CD155 interaction, and might also be helpful for the development of anti-cancer target drugs. This evidence concerns the gene CD226 and autoimmune disease.